The key role of sphingosine kinases in the molecular mechanism of neuronal cell survival and death in an experimental model of Parkinson's disease

被引:55
|
作者
Pyszko, Joanna A. [1 ]
Strosznajder, Joanna B. [1 ]
机构
[1] Polish Acad Sci, Dept Cellular Signalling, Mossakowski Med Res Ctr, Warsaw, Poland
关键词
sphingosine kinases; dopaminergic neurons; apoptosis; PD model; NEUROBLASTOMA SH-SY5Y CELLS; ALPHA-SYNUCLEIN; SPHINGOSINE-1-PHOSPHATE RECEPTORS; SPHINGOLIPID METABOLISM; DOPAMINERGIC-NEURONS; GENE-EXPRESSION; LIPID RAFTS; 1-PHOSPHATE; CERAMIDE; APOPTOSIS;
D O I
10.5114/fn.2014.45567
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Sphingosine kinases (Sphk1/2 EC 2.7.1.91) are responsible for synthesis of sphingosine-1-phosphate (S1P) and for regulation of the bioactive sphingolipids homeostasis. Sphingosine-1-phosphate can act as a potent messenger in an autocrine/paracrine manner through five specific G protein-coupled receptors (GPCR) S1P1-5. This sphingolipid is involved in the mechanism of transcription, mitochondrial function, neuronal viability and degeneration. Until now the involvement of Sphk1/2 and sphingolipid alterations in Parkinson's disease (PD) remains unknown. Recent studies have indicated the role of sphingolipids in the regulation of alpha-synuclein (ASN) in the PD brain. Our latest data demonstrated significant inhibition of Sphk1 gene expression and activity in an in vitro PD model, induced by 1-methyl-4-phenylpyridinium (MPP+). The aim of this study was to investigate the role of Sphks inhibition in ASN secretion and in the molecular mechanism of neuronal death in the PD model. Our study was carried out using neuronal dopaminergic SH-SY5Y control cells, transfected with the human gene for ASN or with an empty vector These cells were treated with MPP+ (1-3 mM), which represents an experimental PD model, or with the Sphks inhibitor (1-5 mu M SKI II) for 3-24 h. Our data indicated that MPP+ (3 mM) induced significant alterations of Sphks and S1P lyase (SPL) gene expression. Reduced activity of Sphk1 and Sphk2 in the cytosolic fraction and in the crude nuclear fraction, respectively, was observed. Sphks inhibition evoked enhancement of ASN secretion, suppression of PI3K/Akt phosphorylation and activation of gene expression for the pro-apoptotic Bcl-2 proteins Bax and BH3-only protein Harakiri. Moreover, a lower level of cytochrome c in the mitochondrial fraction and caspase-dependent degradation of DNA-bound enzyme poly(ADP-ribose) polymerase (PARP-1) were observed. The caspase inhibitor (20 mu M Z-VAD-FMK) significantly enhanced neuronal cell viability in MPP+ oxidative stress. However, exogenous S1P (1 mu M) exerted a more efficient neuroprotective effect as compared to Z-VAD-FMK. In summary, these data indicated that Sphk1 inhibition plays an important role in caspase-dependent apoptotic neuronal death in an experimental PD model.
引用
收藏
页码:260 / 269
页数:10
相关论文
共 50 条
  • [1] The role of sphingosine kinase-1 in alpha-synuclein secretion and neuronal cell death mechanism in an experimental model of Parkinson's disease
    Pyszko, J.
    Strosznajder, J. B.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S642 - S642
  • [2] Biochemical and molecular mechanisms of neuronal cell death in the experimental neurotoxic models of Parkinson's disease
    Lambeng, N
    Hourez, R
    Torch, S
    Verna, JM
    Blum, D
    M S-MEDECINE SCIENCES, 2002, 18 (04): : 457 - 466
  • [3] Mechanism of cell death in experimental models of Parkinson's disease
    Hirsch, EC
    Hunot, S
    Hartmann, A
    FUNCTIONAL NEUROLOGY, 2000, 15 (04) : 229 - 237
  • [4] Molecular mechanism of monoamine toxicity in Parkinson's disease: hypothetical cell death model
    del Rio, MJ
    Velez-Pardo, C
    MEDICAL HYPOTHESES, 2000, 54 (02) : 269 - 274
  • [6] Mechanism of nerve cell death in Parkinson's disease
    Hirsch, E
    BRITISH JOURNAL OF PHARMACOLOGY, 1997, 122 : U148 - U148
  • [7] Modulation of neuronal survival factor MEF2 by kinases in Parkinson's disease
    Yin, Yue
    She, Hua
    Li, Wenming
    Yang, Qian
    Guo, Shuzhong
    Mao, Zixu
    FRONTIERS IN PHYSIOLOGY, 2012, 3
  • [8] Molecular mechanisms of selective dopaminergic neuronal death in Parkinson's disease
    Barzilai, A
    Melamed, E
    TRENDS IN MOLECULAR MEDICINE, 2003, 9 (03) : 126 - 132
  • [9] Molecular Imaging of Cell Death in an Experimental Model of Parkinson’s Disease with a Novel Apoptosis-Targeting Peptide
    Min-Jeong Lee
    Kai Wang
    In-San Kim
    Byung-Heon Lee
    Hyung Soo Han
    Molecular Imaging and Biology, 2012, 14 : 147 - 155
  • [10] Molecular Imaging of Cell Death in an Experimental Model of Parkinson's Disease with a Novel Apoptosis-Targeting Peptide
    Lee, Min-Jeong
    Wang, Kai
    Kim, In-San
    Lee, Byung-Heon
    Han, Hyung Soo
    MOLECULAR IMAGING AND BIOLOGY, 2012, 14 (02) : 147 - 155